» Articles » PMID: 36719377

Neutrophil CEACAM1 Determines Susceptibility to NETosis by Regulating the S1PR2/S1PR3 Axis in Liver Transplantation

Overview
Journal J Clin Invest
Specialty General Medicine
Date 2023 Jan 31
PMID 36719377
Authors
Affiliations
Soon will be listed here.
Abstract

Neutrophils, the largest innate immune cell population in humans, are the primary proinflammatory sentinel in the ischemia-reperfusion injury (IRI) mechanism in orthotopic liver transplantation (OLT). Carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1, CC1, or CD66a) is essential in neutrophil activation and serves as a checkpoint regulator of innate immune-driven IRI cascade in OLT. Although CC1 alternative splicing generates two functionally distinct short and long cytoplasmic isoforms, their role in neutrophil activation remains unknown. Here, we undertook molecular and functional studies to interrogate the significance of neutrophil CC1 signaling in mouse and human OLT recipients. In the experimental arm, we employed a mouse OLT model to document that ablation of recipient-derived neutrophil CC1-long (CC1-L) isotype aggravated hepatic IRI by promoting neutrophil extracellular traps (NETs). Notably, by regulating the S1P-S1PR2/S1PR3 axis, neutrophil CC1-L determined susceptibility to NET formation via autophagy signaling. In the clinical arm, liver grafts from 55 transplant patients selectively enriched for neutrophil CC1-L showed relative resistance to ischemia-reperfusion (IR) stress/tissue damage, improved hepatocellular function, and clinical outcomes. In conclusion, despite neutrophils being considered a principal villain in peritransplant tissue injury, their CC1-L isoform may serve as a regulator of IR stress resistance/NETosis in human and mouse OLT recipients.

Citing Articles

Genome-wide KAS-Seq mapping of leukocytes in ischemia-reperfusion model reveals IL7R as a potential therapeutic target for ischemia-reperfusion injury.

Zhang L, Duolikun M, Chen H, Wang Z, Li X, Xiao H Sci Rep. 2025; 15(1):6165.

PMID: 39979392 PMC: 11842730. DOI: 10.1038/s41598-025-90457-7.


The role of CEACAMs in neutrophil function.

Skubitz K Eur J Clin Invest. 2024; 54 Suppl 2:e14349.

PMID: 39674879 PMC: 11646290. DOI: 10.1111/eci.14349.


Mechanism and function of CEACAM1 splice isoforms.

Dery K, Najjar S, Beauchemin N, Shively J, Kupiec-Weglinski J Eur J Clin Invest. 2024; 54 Suppl 2:e14350.

PMID: 39674874 PMC: 11646291. DOI: 10.1111/eci.14350.


Current investigation of carcinoembryonic antigen cell adhesion molecule (CEACAM) biology summary of the 32nd CEA symposium: 20-23 September 2024. Würzburg, Germany.

Fleckenstein J, Najjar S, Zimmermann W, Hauck C, Nguyen Q, Mejias-Luque R Eur J Clin Invest. 2024; 54 Suppl 2:e14355.

PMID: 39674873 PMC: 11880994. DOI: 10.1111/eci.14355.


Suppression of Hepatocyte Ferroptosis via USP19-Mediated Deubiquitination of SLC7A11 in Ischemia-Free Liver Transplantation.

Xu J, Chen S, Liu D, Zhang Q, Luo T, Zhu J Adv Sci (Weinh). 2024; 12(6):e2406200.

PMID: 39574305 PMC: 11809379. DOI: 10.1002/advs.202406200.


References
1.
Rayes R, Vourtzoumis P, Rjeily M, Seth R, Bourdeau F, Giannias B . Neutrophil Extracellular Trap-Associated CEACAM1 as a Putative Therapeutic Target to Prevent Metastatic Progression of Colon Carcinoma. J Immunol. 2020; 204(8):2285-2294. PMC: 7534954. DOI: 10.4049/jimmunol.1900240. View

2.
Remijsen Q, Vanden Berghe T, Wirawan E, Asselbergh B, Parthoens E, De Rycke R . Neutrophil extracellular trap cell death requires both autophagy and superoxide generation. Cell Res. 2010; 21(2):290-304. PMC: 3193439. DOI: 10.1038/cr.2010.150. View

3.
Rosazza T, Warner J, Sollberger G . NET formation - mechanisms and how they relate to other cell death pathways. FEBS J. 2020; 288(11):3334-3350. DOI: 10.1111/febs.15589. View

4.
Nakamura K, Zhang M, Kageyama S, Ke B, Fujii T, Sosa R . Macrophage heme oxygenase-1-SIRT1-p53 axis regulates sterile inflammation in liver ischemia-reperfusion injury. J Hepatol. 2017; 67(6):1232-1242. PMC: 5884687. DOI: 10.1016/j.jhep.2017.08.010. View

5.
Thalin C, Lundstrom S, Seignez C, Daleskog M, Lundstrom A, Henriksson P . Citrullinated histone H3 as a novel prognostic blood marker in patients with advanced cancer. PLoS One. 2018; 13(1):e0191231. PMC: 5764486. DOI: 10.1371/journal.pone.0191231. View